- Home
- PEV vs TNXP Comparison
PEV vs TNXP Comparison
Compare PEV & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEV
- TNXP
- Stock Information
- Founded
- PEV 2002
- TNXP 2007
- Country
- PEV United States
- TNXP United States
- Employees
- PEV N/A
- TNXP N/A
- Industry
- PEV Auto Manufacturing
- TNXP Biotechnology: Pharmaceutical Preparations
- Sector
- PEV Consumer Discretionary
- TNXP Health Care
- Exchange
- PEV Nasdaq
- TNXP Nasdaq
- Market Cap
- PEV 15.8M
- TNXP 15.1M
- IPO Year
- PEV 2022
- TNXP N/A
- Fundamental
- Price
- PEV $0.70
- TNXP $0.15
- Analyst Decision
- PEV
- TNXP Strong Buy
- Analyst Count
- PEV 0
- TNXP 2
- Target Price
- PEV N/A
- TNXP $53.50
- AVG Volume (30 Days)
- PEV 14.6M
- TNXP 26.1M
- Earning Date
- PEV 11-12-2024
- TNXP 11-07-2024
- Dividend Yield
- PEV N/A
- TNXP N/A
- EPS Growth
- PEV N/A
- TNXP N/A
- EPS
- PEV N/A
- TNXP N/A
- Revenue
- PEV $10,761,000.00
- TNXP $12,458,000.00
- Revenue This Year
- PEV N/A
- TNXP $62.53
- Revenue Next Year
- PEV N/A
- TNXP $26.17
- P/E Ratio
- PEV N/A
- TNXP N/A
- Revenue Growth
- PEV 97.81
- TNXP N/A
- 52 Week Low
- PEV $0.32
- TNXP $0.12
- 52 Week High
- PEV $1.79
- TNXP $22.08
- Technical
- Relative Strength Index (RSI)
- PEV 58.32
- TNXP 32.40
- Support Level
- PEV $0.70
- TNXP $0.14
- Resistance Level
- PEV $1.39
- TNXP $0.18
- Average True Range (ATR)
- PEV 0.12
- TNXP 0.02
- MACD
- PEV 0.05
- TNXP 0.02
- Stochastic Oscillator
- PEV 34.94
- TNXP 28.11
About PEV Phoenix Motor Inc.
Phoenix Motor Inc is an electrification solutions provider for the commercial vehicle industry as well as other industries. It designs, develops, manufactures, assembles, and integrates electric drive systems and light and medium-duty electric vehicles (EVs) and markets and sells electric vehicle chargers for the commercial and residential markets. The company operates two primary brands, Phoenix Motorcars, which focuses on commercial products including medium-duty electric vehicles, chargers, and electric forklifts, and EdisonFuture which intends to offer light-duty electric vehicles.
About TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.